Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers (Q34139838)

31 July 2017

title

Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers (English)

1 reference

31 July 2017

1 reference

2

Andrew V Schally

1 reference

31 July 2017

6

Gabor Halmos

1 reference

31 July 2017

1

Artur Plonowski

1 reference

31 July 2017

Rebeca Busto

3

1 reference

31 July 2017

Magdalena Krupa

series ordinal

4

1 reference

31 July 2017

Jozsef L Varga

series ordinal

5

1 reference

31 July 2017

publication date

1 June 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1127-1133

1 reference

Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Peptide growth factors and prostate cancer: new models, new opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Tissue-specific molecular heterogeneity of human growth hormone-releasing hormone receptor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Molecular and cell biology of the growth hormone-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Radiolabeled somatostatin analogs in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900043-8

7 January 2021

10.1016/S0196-9781(02)00043-8

Identifiers

DOI

1 reference

31 July 2017

1 reference